Physician profile
Anne Egan
NPI 1134846546
$339.33
in general payments reported to CMS, 2019-2025
10 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $74.42 | 2025 | Enhertu, Datroway |
| Merck Sharp & Dohme LLC | $62.68 | 2025 | Keytruda, Welireg |
| Pfizer INC. | $43.32 | 2025 | |
| Incyte Corporation | $36.79 | 2025 | Jakafi, Zynyz, Monjuvi |
| Genentech USA, INC. | $23.29 | 2025 | Tecentriq |
| Syndax Pharmaceuticals, INC. | $22.77 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.49 | 2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $21.24 | 2025 | Provenge |
| Geron Corporation | $16.73 | 2025 | Rytelo |
| Gilead Sciences, INC. | $16.60 | 2025 | Trodelvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Egan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.